NASDAQ:UTHR

United Therapeutics News Headlines

$202.65
+21.99 (+12.17 %)
(As of 08/4/2021 10:38 AM ET)
Add
Compare
Today's Range
$187.50
$205.53
50-Day Range
$170.47
$187.65
52-Week Range
$98.37
$212.62
Volume16,935 shs
Average Volume218,500 shs
Market Capitalization$9.08 billion
P/E Ratio22.39
Dividend YieldN/A
Beta0.47

United Therapeutics (NASDAQ UTHR) News Headlines Today

SourceHeadline
United Therapeutics (NASDAQ:UTHR) Stock Rating Lowered by Zacks Investment ResearchUnited Therapeutics (NASDAQ:UTHR) Stock Rating Lowered by Zacks Investment Research
marketbeat.com - July 20 at 11:40 AM
United Therapeutics Corporation Reports Second Quarter 2021 Financial ResultsUnited Therapeutics Corporation Reports Second Quarter 2021 Financial Results
finance.yahoo.com - August 4 at 8:59 AM
United Therapeutics (UTHR) Q2 Earnings and Revenues Surpass EstimatesUnited Therapeutics (UTHR) Q2 Earnings and Revenues Surpass Estimates
finance.yahoo.com - August 4 at 8:59 AM
Is United Therapeutics (NASDAQ:UTHR) A Risky Investment?Is United Therapeutics (NASDAQ:UTHR) A Risky Investment?
finance.yahoo.com - July 29 at 2:06 PM
United Therapeutics (UTHR) Scheduled to Post Earnings on WednesdayUnited Therapeutics (UTHR) Scheduled to Post Earnings on Wednesday
americanbankingnews.com - July 29 at 10:44 AM
United Therapeutics (UTHR) to Report Q2 Results: Wall Street Expects Earnings GrowthUnited Therapeutics (UTHR) to Report Q2 Results: Wall Street Expects Earnings Growth
finance.yahoo.com - July 28 at 7:26 PM
United Therapeutics Corporation To Report Second Quarter 2021 Financial Results Before The Market Opens On Wednesday, August 4, 2021United Therapeutics Corporation To Report Second Quarter 2021 Financial Results Before The Market Opens On Wednesday, August 4, 2021
finance.yahoo.com - July 28 at 9:25 AM
United Therapeutics Co. (NASDAQ:UTHR) Given Consensus Rating of "Buy" by AnalystsUnited Therapeutics Co. (NASDAQ:UTHR) Given Consensus Rating of "Buy" by Analysts
americanbankingnews.com - July 18 at 8:16 AM
United Therapeutics Corporation Common Stock (UTHR)United Therapeutics Corporation Common Stock (UTHR)
nasdaq.com - July 17 at 7:32 PM
United Therapeutics (NASDAQ:UTHR) Raised to Buy at ArgusUnited Therapeutics (NASDAQ:UTHR) Raised to Buy at Argus
americanbankingnews.com - July 14 at 9:43 AM
United Therapeutics Announces The Lancet Respiratory Medicine Publication Of Post-Hoc Analysis Of FVC Change From The Tyvaso® INCREASE StudyUnited Therapeutics Announces The Lancet Respiratory Medicine Publication Of Post-Hoc Analysis Of FVC Change From The Tyvaso® INCREASE Study
finance.yahoo.com - July 8 at 2:50 AM
United Therapeutics (UTHR) Tyvaso DPI Gets FDAs Priority TagUnited Therapeutics (UTHR) Tyvaso DPI Gets FDA's Priority Tag
finance.yahoo.com - June 17 at 10:18 AM
United Therapeutics gets one step closer to another product approvalUnited Therapeutics gets one step closer to another product approval
bizjournals.com - June 16 at 4:02 PM
MannKind Shares Rise as Partners Drug Gets FDA Priority ReviewMannKind Shares Rise as Partner's Drug Gets FDA Priority Review
msn.com - June 16 at 10:53 AM
MannKind - United Therapeutics Formulated Treprostinil Under FDA Review For Pulmonary HypertensionMannKind - United Therapeutics' Formulated Treprostinil Under FDA Review For Pulmonary Hypertension
finance.yahoo.com - June 16 at 10:53 AM
Declining Stock and Decent Financials: Is The Market Wrong About United Therapeutics Corporation (NASDAQ:UTHR)?Declining Stock and Decent Financials: Is The Market Wrong About United Therapeutics Corporation (NASDAQ:UTHR)?
finance.yahoo.com - June 14 at 7:55 PM
United Therapeutics Pursues New Claims For Trade Secret Misappropriation Against LiquidiaUnited Therapeutics Pursues New Claims For Trade Secret Misappropriation Against Liquidia
finance.yahoo.com - June 7 at 7:36 AM
Why Is United Therapeutics (UTHR) Down 8.8% Since Last Earnings Report?Why Is United Therapeutics (UTHR) Down 8.8% Since Last Earnings Report?
finance.yahoo.com - June 4 at 3:06 PM
United Therapeutics (UTHR) Begins TETON Study on Tyvaso in IPFUnited Therapeutics (UTHR) Begins TETON Study on Tyvaso in IPF
finance.yahoo.com - June 4 at 10:05 AM
United Therapeutics Corporation To Present At The Jefferies Virtual Healthcare ConferenceUnited Therapeutics Corporation To Present At The Jefferies Virtual Healthcare Conference
finance.yahoo.com - June 2 at 9:51 AM
UTHR May 2021 165.000 putUTHR May 2021 165.000 put
uk.finance.yahoo.com - May 22 at 11:25 PM
United Therapeutics Corporation (UTHR) CEO Martine Rothblatt on Q1 2021 Results - Earnings Call TranscriptUnited Therapeutics Corporation (UTHR) CEO Martine Rothblatt on Q1 2021 Results - Earnings Call Transcript
seekingalpha.com - May 7 at 8:38 AM
United Therapeutics EPS in-line, beats on revenueUnited Therapeutics EPS in-line, beats on revenue
seekingalpha.com - May 6 at 5:29 PM
Price Over Earnings Overview: United TherapeuticsPrice Over Earnings Overview: United Therapeutics
benzinga.com - May 6 at 12:29 PM
United Therapeutics (UTHR) Q1 Earnings Miss, Sales BeatUnited Therapeutics (UTHR) Q1 Earnings Miss, Sales Beat
finance.yahoo.com - May 6 at 12:29 PM
United Therapeutics Corp (UTHR) Q1 2021 Earnings Call TranscriptUnited Therapeutics Corp (UTHR) Q1 2021 Earnings Call Transcript
finance.yahoo.com - May 5 at 4:14 PM
United Therapeutics (UTHR) Lags Q1 Earnings EstimatesUnited Therapeutics (UTHR) Lags Q1 Earnings Estimates
finance.yahoo.com - May 5 at 11:13 AM
If You Had Bought United Therapeutics (NASDAQ:UTHR) Shares A Year Ago Youd Have Earned 86% ReturnsIf You Had Bought United Therapeutics (NASDAQ:UTHR) Shares A Year Ago You'd Have Earned 86% Returns
finance.yahoo.com - April 28 at 3:47 PM
Earnings Preview: United Therapeutics (UTHR) Q1 Earnings Expected to DeclineEarnings Preview: United Therapeutics (UTHR) Q1 Earnings Expected to Decline
finance.yahoo.com - April 28 at 3:47 PM
United Therapeutics Gets a Second WindUnited Therapeutics Gets a Second Wind
finance.yahoo.com - April 26 at 4:39 PM
United Therapeutics Corporation To Report First Quarter 2021 Financial Results Before The Market Opens On Wednesday, May 5, 2021United Therapeutics Corporation To Report First Quarter 2021 Financial Results Before The Market Opens On Wednesday, May 5, 2021
finance.yahoo.com - April 26 at 6:38 AM
United Therapeutics takes latest step in aggressive push to launch more productsUnited Therapeutics takes latest step in aggressive push to launch more products
bizjournals.com - April 19 at 1:59 PM
Mannkind and United Therapeutics Reach a Milestone in the Development of Tyvaso DPI™ With New Drug Application Submitted to the FDAMannkind and United Therapeutics Reach a Milestone in the Development of Tyvaso DPI™ With New Drug Application Submitted to the FDA
markets.businessinsider.com - April 19 at 8:56 AM
Mannkind and United Therapeutics Reach a Milestone in the Development of Tyvaso DPI(TM) With New Drug Application Submitted to the FDAMannkind and United Therapeutics Reach a Milestone in the Development of Tyvaso DPI(TM) With New Drug Application Submitted to the FDA
marketwatch.com - April 19 at 8:56 AM
Is UTHR Stock A Buy or Sell?Is UTHR Stock A Buy or Sell?
finance.yahoo.com - April 6 at 6:55 PM
United Therapeutics (UTHR) Gains on Tyvaso Label ExpansionUnited Therapeutics (UTHR) Gains on Tyvaso Label Expansion
finance.yahoo.com - April 5 at 12:53 PM
This Pharma Can Breathe New Life Into Your PortfolioThis Pharma Can Breathe New Life Into Your Portfolio
finance.yahoo.com - April 2 at 9:10 AM
United Therapeutics Receives FDA Approval For Tyvaso Therapy; Shares Pop 15%United Therapeutics Receives FDA Approval For Tyvaso Therapy; Shares Pop 15%
finance.yahoo.com - April 2 at 9:10 AM
United Therapeutics Jumps as FDA Clears Hypertension DrugUnited Therapeutics Jumps as FDA Clears Hypertension Drug
thestreet.com - April 1 at 1:52 PM
United Therapeutics: FDA Approves Tyvaso For PH-ILD - Quick FactsUnited Therapeutics: FDA Approves Tyvaso For PH-ILD - Quick Facts
nasdaq.com - April 1 at 8:50 AM
UTHR Aug 2021 160.000 putUTHR Aug 2021 160.000 put
ca.finance.yahoo.com - March 27 at 3:16 PM
UTHR May 2021 110.000 callUTHR May 2021 110.000 call
ca.finance.yahoo.com - March 27 at 9:52 AM
UTHR Aug 2021 200.000 putUTHR Aug 2021 200.000 put
ca.finance.yahoo.com - March 27 at 9:52 AM
Why Is United Therapeutics (UTHR) Down 0.3% Since Last Earnings Report?Why Is United Therapeutics (UTHR) Down 0.3% Since Last Earnings Report?
finance.yahoo.com - March 26 at 1:28 PM
UTHR May 2021 75.000 putUTHR May 2021 75.000 put
sg.finance.yahoo.com - March 18 at 9:28 AM
United Therapeutics Corporation To Present At The Oppenheimer 31st Annual Healthcare ConferenceUnited Therapeutics Corporation To Present At The Oppenheimer 31st Annual Healthcare Conference
finance.yahoo.com - March 17 at 8:45 AM
United Therapeutics Pulls Plug On Trevyent DevelopmentUnited Therapeutics Pulls Plug On Trevyent Development
finance.yahoo.com - March 3 at 2:34 PM
Looking Into United Therapeuticss Return On Capital EmployedLooking Into United Therapeutics's Return On Capital Employed
finance.yahoo.com - March 3 at 2:34 PM
United Therapeutics Corporation Just Missed Earnings - But Analysts Have Updated Their ModelsUnited Therapeutics Corporation Just Missed Earnings - But Analysts Have Updated Their Models
finance.yahoo.com - February 27 at 1:30 PM
United Therapeutics (UTHR) Q4 Earnings Miss, Sales BeatUnited Therapeutics (UTHR) Q4 Earnings Miss, Sales Beat
nasdaq.com - February 25 at 10:11 AM
United Therapeutics Corp (UTHR) Q4 2020 Earnings Call TranscriptUnited Therapeutics Corp (UTHR) Q4 2020 Earnings Call Transcript
finance.yahoo.com - February 24 at 7:58 PM
This page was last updated on 8/4/2021 by MarketBeat.com Staff
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research.